Marksans Pharma Company Description

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas.

Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids.

The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers.

Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Marksans Pharma Limited

Country	India
Founded	1992
Industry	Drug Manufacturers - General
Sector	Healthcare
Employees	1,840
CEO	Mark Saldanha

Contact Details

Address: Grandeur Mumbai, 400053 India
Phone	91 22 4001 2000
Website	marksanspharma.com

Stock Details

Ticker Symbol	MARKSANS
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE750C01026
SIC Code	2834

Key Executives

Name	Position
Mark B. Saldanha	Non-Independent Executive Chairman and MD
Jitendra M. Sharma	Group Chief Financial Officer
Harshavardhan Panigrahi	Company Secretary, Manager of Legal and Compliance Officer
Sandra Saldanha	Whole-Time Executive Non Independent Director
Varddhman Vikramaditya Jain	Whole-Time Executive Non Independent Director
Vishal Bhargava	Director Operations
David Mohammed	Managing Director of Australia Operations
Sunil K. Rane	Senior Vice President of QC
Sathish Kumar	Managing Director of UK Operations
Anjani Kumar	Chief Operating Officer of US Operations